Sign In

Naomi Fried

CEO & Founder PharmStars; Managing Partner & Co-founder, Ambit Health Ventures

Professional Background

Naomi Fried, Ph.D., is a highly regarded leader in the field of healthcare innovation with over two decades of experience in driving strategic initiatives, managing innovation programs, and building infrastructure that enhances healthcare delivery. As the founder and CEO of Health Innovation Strategies (HealthIS), Dr. Fried is dedicated to transforming the landscape of healthcare through innovative approaches to digital health. Her extensive background includes significant roles at prestigious organizations where she has crafted and executed groundbreaking strategies that have not only advanced technology but have also fostered an environment of collaborative, patient-centered care.

As the inaugural Chief Innovation Officer at Boston Children’s Hospital, Dr. Fried established the highly acclaimed Innovation Acceleration Program, which was instrumental in bridging the gap between innovative ideas and their implementation in clinical settings. Her leadership inspired a culture of creativity and excellence, resulting in numerous successful healthcare innovations. Moreover, during her tenure as Kaiser Permanente’s first Vice President of Innovation and Advanced Technology, Dr. Fried laid the foundation for future advancements in healthcare delivery that leveraged cutting-edge technology. Her previous role at Biogen saw her spearheading the "Innovation Beyond the Molecule" program, a testament to her forward-thinking approach to leveraging innovation in biotechnology and pharmaceuticals.

In addition to her corporate roles, Dr. Fried has a dynamic entrepreneurial spirit and is passionate about developing capabilities that will enhance healthcare. Throughout her career, she has also served in key advisory positions, drawing upon her rich experience to bolster new ventures and startups, such as her recent role as Managing Partner and Co-Founder at Ambit Health Ventures.

Education and Achievements

Dr. Fried's academic journey has laid a solid foundation for her success in the healthcare innovation sector. She obtained her Bachelor of Science in Chemistry from the esteemed University of California, Berkeley, known for its rigorous scientific curriculum. Following this, she earned a Ph.D. in Materials Science Engineering from the renowned Massachusetts Institute of Technology (MIT), an institution widely recognized for its cutting-edge research and innovation.

Dr. Fried's prestigious education has significantly contributed to her comprehensive understanding of both the scientific and business aspects of healthcare, enabling her to effectively bridge gaps between technical research, innovation, and practical applications within the healthcare system. Her specialization includes expertise in digital health, telehealth, mobile health, and digital transformation, where she actively advocates for connected health solutions.

Board Membership

Dr. Naomi Fried is not only a leader in innovation but also an influential voice in the healthcare sector through her positions on various boards. As a member of the American Telemedicine Association, she plays a vital role in promoting the growth of telemedicine and ensuring that healthcare delivery is enhanced via innovative digital health strategies. Furthermore, her contributions as a Governor of the Massachusetts' Innovation Council showcase her commitment to fostering innovation across the state, positioning Massachusetts as a leading hub for healthcare advancements.

Contributions to Innovation

Dr. Fried’s involvement in numerous organizations highlights her significant contributions to the healthcare innovation landscape. As a creator of the Healthcare "Innovation Life Cycle" paradigm, she has developed frameworks that guide organizations in assessing and implementing innovative strategies effectively. Her firm, Health Innovation Strategies, serves to empower healthcare organizations through tailored consulting services that align innovation capabilities with strategic goals.

Furthermore, her role on advisory boards for firms like ResApp Health and nQ Medical Inc exemplifies her commitment to guiding new technologies that aim to disrupt traditional healthcare modalities with effective, patient-centric solutions. Dr. Fried's influence in the healthcare technology sector also extends to her contributions during her time at Partners HealthCare, where strategic advice and innovative management were pivotal in ensuring excellence in service delivery across the health system.

Achievements

Dr. Fried's extensive career is accentuated by numerous achievements and accolades in the field of healthcare innovation. She has played critical roles in large healthcare organizations, leveraging her knowledge and experience to formulate innovative strategies that have transformed patient care. Her successful mentorship and development of talented teams reflect her commitment to cultivating the next generation of healthcare leaders.

Moreover, th

Highlights

Jun 28 · linkedin

📣 Attention #VCs: Do you have a #digitalhealth #startup 🚀 with an #innovation related to “Therapeutic Delivery” in your portfolio that wants to do business with #pharma? If they have only a few (or no) pharma clients, 💥PharmStars can provide them with access to many more potential pharma clients.   Startups in our #acceleratorprogram have the unique opportunity to pitch to and meet one-on-one with our pharma members at our private Showcase Event. It's an amazing way to accelerate a startup's pharma #businessdevelopment pipeline! There were 60+ one-on-one, private pharma-startup meetings 🤝 at our Showcase Event in May.   Our virtual, #pharmastartupgap-focused #accelerator coaches and educates startups on how to optimize their pharma value proposition-- which leads to successful business engagements with pharma. Even participants with 15+ years of pharma experience gain valuable insights from our educational #PharmaU program. PharmaU also includes personalized coaching by seasoned former pharma executives.   No #equity required to participate in our #acceleratorprogram- just tuition and a success payment when deals are closed.   Startups can be of any age/stage welcome, but must have a product or prototype to offer pharma now.  We have had pre-seed through Series B startups thrive in our program.   Areas of interest include, but are not limited to:   🌟Novel drug delivery/ administration platforms 💡 Companion devices 💡 Dynamic dosing   🌟Supply chain management or efficiency 💡 Sourcing, logistics, distribution, inventory, compliance 💡 Product integrity, tracking anti-counterfeiting 💡 Supply and delivery for advanced therapies (cell, gene, etc.) 💡 Sustainability and recycling   🌟 Treatment management 💡 Patient education, health literacy 💡 Medication adherence and persistence 💡 Remote patient monitoring 💡 Avoiding and/or detecting drug-drug interactions 💡 Detection, monitoring, measuring, managing or reporting side effects   ⏰ Hurry! Time is running out! The application deadline is July 10.   Info and applications 👉 https://lnkd.in/d-Qe7R4y   #venturecapital #Investment #entrepreneur #Investors #transformation #partnerships #biotech #bizdev #engagement #financing #funding #biopharma

Mar 14 · linkedin

Today we continue PharmStars' tribute🎉 to the fabulous #femalefounders who have graduated from our #accelerator during Women’s (Making!) History Month. I am delighted to feature 4 founders and CEOs from our Spring 2022 cohort focused on #digitalhealth #innovations in #NeurologicalDisease:

Teri Chou is CEO of Modus Health (Edmonds, WA), a validated, real world #mobility assessment tool. Modus’ #wearable and #digitalendpoints are used worldwide for a more reliable measure of walking quantity, intensity, and duration.  In a comparison study, Modus demonstrated superior accuracy of 98%. We congratulate Modus on actively supporting a Phase 3 trial in 55 sites worldwide!

Patty Lee is CEO of Orbit Health (Munich, Germany), an #AI-enabled, wearable-agnostic platform to track and evaluate #ParkinsonsDisease. Their platform, which uses commercially available smart watches, offers objective, convenient, minute-by-minute information on #motorsymptoms and treatment responses in real world settings. Orbit Health’s system has been validated and tracks disease progression and supports treatment #personalization, enhancing patient engagement, and care optimization.

Charisse Litchman is co-founder and Chief Medical Officer at BeCare Link (Rumson, NJ), a gamified, #mobileapp for #AI-enabled #neurologicalassessment. BeCare Link delivers a remote, #quantitative assessment of neurological function with AI analysis, from data it collects along with other digital biomarkers. BeCare Link provides clinicians and investigators a more sensitive, reliable, faster, and more #comprehensive neurological evaluation than standard clinical assessments.

Carla Zaldua Aguirre is CEO of acceXible (Barcelona, Spain), a device-agnostic #speechbiomarker platform for #screening and monitoring #mildcognitiveimpairment and early #dementia with a sensitivity of 91% and a specificity of 89%. Their tool is objective and scalable and their speech biomarkers are available in #multiplelanguages.

The contributions these fantastic women are making to the field are phenomenal. As a community, we are excited to support and cheer these impressive #digitalhealth #startups and their #CEOs! Happy #WomensHistoryMonth!

Shwen Gwee, Laura Gunn, Meredith Cohen, Shrawan Patel, MD, Elizabeth Otter, MPH Marc Monseau, Christopher L. Salzo, Veena Rao, Katherine Vandebelt, Nishta Rao, #pharmstarsalumni #pharma #biopharma #biotech #transformation

Related Questions

How has Naomi Fried's experience as the first Chief Innovation Officer at Boston Children's Hospital shaped her approach to healthcare innovation?
What inspired Naomi Fried to create the Healthcare 'Innovation Life Cycle' paradigm?
In what ways does Naomi Fried leverage her extensive experience in digital health to impact healthcare organizations?
How does Naomi Fried's educational background in Chemistry and Materials Science contribute to her success in healthcare innovation?
What achievements during Naomi Fried's tenure at Biogen exemplify her innovative approach to biotechnology?
Naomi Fried
Add to my network

Location

Greater Boston